Skip to Main Content
Everyone (Public)

EMD Seminar Series: Merryn Voysey - "Seroefficacy of pneumococcal conjugate vaccines"

Merryn Voysey is Professor of Statistics in Vaccinology at the Oxford Vaccine Group. She has extensive experience in leading vaccines research including clinical trials and observational studies, and was the lead methodologist for the Oxford-AstraZeneca vaccine trials. Merryn is the Principal Investigator of a global study of measles seroprevalence in infants from 9 countries, and is Chief Investigator of a randomized controlled trial assessing the early administration of measles vaccination in Ugandan infants. With funding from the Bill & Melinda Gates Foundation, she is principal investigator of studies investigating the contribution of T-cell immunity to protection against SARS-CoV-2 infection, correlates of protection and vaccine efficacy for group B streptococcus vaccines, and a study of pneumococcal vaccine seroefficacy. In addition, she is co-investigator on the EDCTP3 funded PROTECT study: Preparing for Optimal Phase III/IV maternal Group B Streptococcal vaccine trials in Africa.





YSPH values inclusion and access for all participants.

If you have questions about accessibility or would like to request an accommodation, please contact Christina Ciarleglio at christina.ciarleglio@yale.edu.

Speaker

  • University of Oxford

    Merryn Voysey
    Professor of Statistics in Vaccinology

Contacts

Admission

Free

Tag

Lectures and Seminars

Next upcoming occurrences of this event

Feb 202519Wednesday